United States · FDA National Drug Code directory
Increlex
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 15054-1040_21eb91ba-3cd8-47f0-a27b-35e3e5fd2e10
- Product NDC
- 15054-1040
- Form
- INJECTION, SOLUTION
- Composition / generic term
- mecasermin
- Labeler
- Ipsen Biopharmaceuticals, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20060103 / 20271231
Source-listed ingredients
- MECASERMIN — 40 mg/4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE · 15054-1040-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →